PATENT CLAIM ANALYSIS

Application Number: 15764193
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "193000"]

Abstract:
Thalidomide analogs and methods of using the thalidomide analogs are disclosed. Some embodiments of the disclosed compounds exhibit anti-angiogenic and/or anti-inflammatory activity. Certain embodiments of the disclosed compounds are non-teratogenic.

Claim (Index 6):
The thalidomide analog according to  claim 1 , wherein the thalidomide analog is:

Metadata:
- Claim Count in Document: 36.0
- Percentile: 90.0
- Lexical Diversity: 1.57143
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13153355', '12767647', '10572485', '13498067', '13648625']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.782192302546611
- 35 USC 102 Novelty (BERT): 0.5181877477530424
- Combined Prediction Score: 0.7557918470672542
- Mean Citation Score: 257.70049
- Max Citation Score: 277.90332
- Similarity Product: 167.81271683099268

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test